Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AML
2019 · Blood · 33 citations
https://doi.org/10.1182/blood-2019-126065
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
594
Citations
7
h-index
7
i10-index
Sonia Esparza is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Neurofibromatosis and Schwannoma Cases & Acute Myeloid Leukemia Research & Meningioma and schwannoma management. The author has an h-index of 7, co-authored 11 publications.
ORCID: 0000-0001-5148-527XClick to start Chat